Stay updated on Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial

Sign up to get notified when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    New: Revision: v3.3.3 added to the record history. The HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page footer.
    Difference
    0.2%
    Check dated 2025-12-23T08:38:47.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The record history now shows Revision: v3.3.2 as the latest version, replacing Revision: v3.3.1.
    Difference
    0.1%
    Check dated 2025-12-01T17:25:21.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Record History now shows a new Revision: v3.3.1 and the removal of Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:35:00.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Removed the banner note about a lapse in government funding and related operating status from the page.
    Difference
    0.7%
    Check dated 2025-11-17T06:42:13.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    New entries appear in the Record History with updates to Study Status and Eligibility across multiple versions, reflecting changes to recruitment and oversight details of the study.
    Difference
    0.1%
    Check dated 2025-11-03T01:14:30.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    - Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.
    Difference
    12%
    Check dated 2025-10-05T10:11:34.000Z thumbnail image

Stay in the know with updates to Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.